Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following α-interferon therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 2, 2001, Pages 196-201

  Shimizu, Ichiro ^a   Omoya, Toshihiro ^a   Takaoka, Tukasa ^b   Wada, Satoshi ^c   Wada, Hisanori ^d,e   Taoka, Masayo ^e   Hayashi, Hideki ^f   Hayashi, Shigehito ^a   Honda, Hirohito ^a   Sano, Nobuya ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Handa Hospital   (Japan)

^c Oe Kyodou Hospital   (Japan)

^d Anan Central Hospital of the Medical Association   (Japan)

^e Medical Adviser of Taoka Hospital   (Japan)

^f Hoetsu Hospital   (Japan)

Author keywords

7S domain of type IV collagen; Amino terminal propeptide of type III procollagen; Chronic hepatitis C; Hepatic fibrosis; Hepatic iron; Interferon

Indexed keywords

ALPHA INTERFERON; COLLAGEN TYPE 4; IRON; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG MECHANISM; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0035098891     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02402.x     Document Type: Article

References (41)

1. The interferons: Mechanisms of action and clinical applications
2. α-Interferon in the treatment of chronic viral hepatitis: Effects on fibrogenesis serum markers
3. 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation
4. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha
5. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level
6. Long-term administration of natural interferon-α in patients with chronic hepatitis C: Relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus
7. Interferon and collagen production
8. Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alphabeta, and -gamma
9. Differential effects of γ-interferon on collagen and fibronectin gene expression
10. Effects of various cytokines on collagen synthesis by normal rat hepatocytes in primary cultures and fibroblasts
11. Cellular sources of collagen and regulation of collagen production in liver
12. Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis
13. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen (I) gene expression in human liver fat-storing cells
14. Role of free radicals in liver diseases and hepatic fibrosis
15. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis
16. Fibrogenic effect of oxidative stress on rat hepatic stellate cells
17. Oxidative mechanisms in the toxicity of metal ions
18. Elevation of the level of lipid peroxidation associated with hepatic injury in LEC mutant rat
19. Measurement of iron status in patients with chronic hepatitis
20. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects
21. Liver fibrosis and extracellular matrix
22. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease
23. Increased serum levels of hyaluronate in liver disease
24. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease
25. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: Diagnostic implications
26. Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China
27. Classification of chronic hepatitis: Diagnosis, grading and staging
28. Improvement of serum amino-transferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron
29. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
30. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload
31. Iron status and cellular immune competence
32. Increased iron stores are a common finding in chronic viral hepatitis
33. A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis
34. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
35. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: A predictive marker for IFN therapy
36. The influence of iron on chronic hepatitis C
37. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C
38. Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables
39. 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection
40. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C
41. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alfa therapy